Neuralstem in the News
NFL group, company teaming up for brain drug test
AP coverage of Neuralstem-National Football League Alumni Association initiative to develop a trial for treating NFL alumni members suffering from traumatic brain injuries with neurogenic NSI-189 was carried by numerous media outlets ranging from ABC News to The Washington Post.
NFL Alumni Back New Drug to Keep Brain-Injuries From “Destroying Quality of Life”
The NSI-189/TBI initiative by Neuralstem and the National Football League Alumni Association, to develop a trial to treat traumatic brain injury for former NFL players, is spotlighted.
Drug which could reverse depression symptoms draws interest of NFL Alumni Association
Lee Nystrom, Chairman of the Board, Emeritus of the NFL Alumni Association, which is headquartered in Newark, New Jersey, and Neuralstem’s CEO and President Richard Garr are quoted in this article about the new NFLAA-Neuralstem NSI-189/TBI initiative.
Neuralstem, NFL Alumni Association To Test Feasibility Of Traumatic Brain Injury Treatment
Neuralstem’s NSI-189/traumatic brain injury initiative announcement with the NFLA received widespread coverage, including this posting to The Huffington Post.
Football and Concussions: New Drug To Be Tested on NFL Alumni
The promise of hope for “Finally, a possible solution to contact sport related head injuries” is cited in this article which highlights Neuralstem’s and the NFLA’s new initiative to develop a trial to treat traumatic brain injury for former NFL players.
Select media coverage in this website is provided for the information and convenience of the public, and is not intended to be all-encompassing nor an endorsement of the specific stories or media outlets.